The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Angioedema (may cause UAO, asphyxia and death)
Publications
Hypersensitivity to chemotherapeutics: a cross sectional study with 35 desensitisations.
International journal of clinical oncology 2015 Apr;20;395-404 — 2015 Apr — 395-404
Acute life-threatening toxicity of cancer treatment.
Critical care clinics 2001 Jul;17;483-502 — 2001 Jul — 483-502
Risk of severe acute hypersensitivity reactions after rapid paclitaxel infusion of less than 1-h duration.
Cancer chemotherapy and pharmacology 1998;42;509-11 — 1998 — 509-11
Anaphylactoid reactions to methotrexate.
Cancer 1996 May 15;77;2123-6 — 1996 May 15 — 2123-6
Carboplatin hypersensitivity in children. A report of five patients with brain tumors.
Cancer 1995 Mar 01;75;1171-5 — 1995 Mar 01 — 1171-5
Hypersensitivity reactions to epipodophyllotoxins in children with acute lymphoblastic leukemia.
Cancer 1991 Feb 15;67;1070-5 — 1991 Feb 15 — 1070-5